Search

Your search keyword '"Humam Kadara"' showing total 259 results

Search Constraints

Start Over You searched for: Author "Humam Kadara" Remove constraint Author: "Humam Kadara" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
259 results on '"Humam Kadara"'

Search Results

1. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics

2. Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer

4. Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

5. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

6. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

7. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

8. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

9. Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer

10. Comprehensive T cell repertoire characterization of non-small cell lung cancer

11. 962 Integrative immunomics highlight the immunomodulatory impact of neoadjuvant chemotherapy and immune-based treatments in resected non-small-cell lung cancer

12. Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon

13. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer

14. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

15. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lungResearch in context

16. Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

17. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment

18. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets.

19. Sex differences in gene expression with galactosylceramide treatment in Cln3Δex7/8 mice.

20. Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer

21. Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform

22. Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From Gprc5a-Deficient Murine Lung Adenocarcinoma With Somatic Kras Mutations

23. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

24. Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models

25. Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes

26. Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria

27. Smoking and Lung Cancer: A Geo-Regional Perspective

28. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

29. The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma

30. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

31. Supplementary Data from The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma

32. Supplementary Figure from The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma

33. Data from The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma

34. Supplementary Fig S8 from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

35. Supplementary Table 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

36. Supplementary Figures and Table from IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties

37. Supplementary Fig S10-S20 from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

38. Supplementary Methods, Table S2 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

39. Data from Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma

40. Perspective on this Article from Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System

41. Data from IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties

42. Supplementary Table 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

43. Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

44. Supplementary Figure from Chronic Exposure to Waterpipe Smoke Elicits Immunomodulatory and Carcinogenic Effects in the Lung

45. Supplementary Materials from Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System

46. Supplementary Figures 1 - 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

47. Supplementary Tables 1-5 from Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma

48. Supplementary Figure S1 Details from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

49. Manuscript supplement from Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma

50. Data from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Catalog

Books, media, physical & digital resources